Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes
Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells.
- New Findings Suggest Keratin Ingredient Cynatine FLX Activates Joint Defense Enzymes
Recent laboratory research on rats suggests that the new keratin joint ingredient Cynatine FLX activates two important joint antioxidant defense enzymes (glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD)) and stimulates the regeneration of cells.
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Broccoli Sprouts Found to Boost Body's Ability to Eliminate Cancer-Causing Toxins in Human Study
A team from Johns Hopkins University School of Medicine and Bloomberg School of Public Health, in collaboration with scientists at the Qidong Liver Cancer Institute, Jiao Tong University in Shanghai and the University of Minnesota Cancer Center, in a blinded placebo-controlled study published in the November issue of Cancer Epidemiology Biomarkers & Prevention, have observed that broccoli sprouts can help the body detoxify carcinogens, which may reduce the risk of developing liver cancer. The study used Three-day-old broccoli sprouts with known levels of sulforaphane glucosinolate (SGS(TM)) and involved 200 subjects in total
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Clinical Study Finds Ginkgo Extract EGb 761(R) Improves Quality of Life of Typical Alzheimer's Patients
Results of the double-blind, placebo-controlled trial were presented at the 21st International Conference of Alzheimer's Disease International, indicate that Ginkgo biloba extract EGb 761(R) (manufactured by the Dr. Willmar Schwabe Company), improve cognitive functions, neuropsychiatric symptoms and the ability to perform daily living activities among typical Alzheimer's patients.
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Clinical Study on Litozin to be presented at 10th World Congress on Osteoarthritis
A poster detailing the effect of Litozin on decreasing cholesterol levels, as well as alleviating symptoms of osteoarthritis will be presented at the Osteoarthritis Research Society International World Congress in Boston, Massachusetts on December 8, 2005.
- Clinical Study on Litozin to be presented at 10th World Congress on Osteoarthritis
A poster detailing the effect of Litozin on decreasing cholesterol levels, as well as alleviating symptoms of osteoarthritis will be presented at the Osteoarthritis Research Society International World Congress in Boston, Massachusetts on December 8, 2005.
- New Study Indicates That ChromeMate(R) Increases Lifespan of Test Animals
A study, conducted by researchers at Georgetown University Medical Center (Washington, DC) and Creighton University Medical Center (Omaha, NE), presented at the Annual Meeting of the American College of Nutrition, indicates that rats fed a diet supplemented with ChromeMate (oxygen-coordinated, niacin-bound chromium) had an average lifespan that was 22% greater than rats fed the same diet without supplementation.
- New Study Indicates That ChromeMate(R) Increases Lifespan of Test Animals
A study, conducted by researchers at Georgetown University Medical Center (Washington, DC) and Creighton University Medical Center (Omaha, NE), presented at the Annual Meeting of the American College of Nutrition, indicates that rats fed a diet supplemented with ChromeMate (oxygen-coordinated, niacin-bound chromium) had an average lifespan that was 22% greater than rats fed the same diet without supplementation.
- Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine
The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit.
- Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine
The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit.
- Herb Science Group’s Letter Regarding Low Dosage in Echinacea Trial Published in New England Journal of Medicine
The New England Journal of Medicine [NEJM] has published a letter to the editor from the American Botanical Council (written by ABC Founder and Executive Director Mark Blumenthal and Norman R. Farnsworth, PhD, Research Professor of Pharmacognosy and Senior University Scholar at the College of Pharmacy at the University of Illinois at Chicago) regarding the low dosage of Echinacea extracts used in a recent clinical trial. The letter suggested that the dosage administered in the trial may have been too low to produce an appreciable benefit.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Groupe DANONE Research Center teams up with Pasteur Institute for probiotics (1) research
Groupe DANONE's Research Center and the Pasteur Institute have undertaken a joint program to deepen scientific knowledge of the way probiotics work.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Glucosamine Studied in Mouse Model of Multiple Sclerosis
Using a mouse model of Multiple Sclerosis (MS) in an animal study published in the Journal of Immunology, glucosamine dramatically delayed the onset of symptoms and improved the animal's ability to move and walk.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Study Finds Omega-3 Fatty Acids Help Decrease Postpartum Depression
randomized dose-ranging pilot trial of Omega-3 fatty acids for post-partum depression indicates that scores on depression measures decreased by approximately 50 percent, and were statistically significant.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Sunflower Seeds, Pistachios Among Top Nuts for Lowering Cholesterol
Chemists at Virginia Polytechnic Institute and State University in Blacksburg, Va., analyzed some 27 nut and seed products and found that pistachios and sunflower kernels had the highest levels of phytosterols among the nuts and seeds that are most commonly consumed as snack foods in the United States.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Study Examines Ability of Vitamin To Help Treatment-resistant Asthma
Researchers from King's College London have found that vitamin D3 could substantially improve the responsiveness of these patients to steroid treatment for asthma attacks.
- Vitamin D Can Play Role in Lung Health
study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D.
- Vitamin D Can Play Role in Lung Health
study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D.
- Vitamin D Can Play Role in Lung Health
study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D.
- Vitamin D Can Play Role in Lung Health
study in the December issue of CHEST shows that patients with higher concentrations of vitamin D had significantly better lung function, compared with patients with lower concentrations of vitamin D.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Hyperforin Plasma Level Inconsistency Found in 2002 St. John’s Wort Study
An article that was quietly presented in a medical journal last summer reported significant disparities in hyperforin plasma levels in many of the participants in a study on St. John’s wort (Hypericum perforatum) and major depression that had been published in the Journal of the American Medical Association (JAMA) over 3 years earlier.
- Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer
Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer.
- Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer
Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer.
- Landmark Study Finds Tea Consumption Associated With Reduced Risk of Ovarian Cancer
Study published in the latest issue of Archives of Internal Medicine indicates that black tea consumption is inversely associated with the risk of ovarian cancer.
- Omega-3 Fatty Acids Can Improve Lung Function
Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD).
- Omega-3 Fatty Acids Can Improve Lung Function
Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD).
- Omega-3 Fatty Acids Can Improve Lung Function
Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD).
- Omega-3 Fatty Acids Can Improve Lung Function
Japanese researchers find that a diet rich in omega-3 fatty acids can have anti-inflammatory effects and improve the exercise capacity for patients with chronic obstructive pulmonary disease (COPD).
- High Intake Of Dietary Fiber Not Associated With Reduced Risk Of Colorectal Cancer
study in the December 14 issue of JAMA examines data from 13 studies, and shows most prospective cohort studies have found no association between dietary fiber intake and risk of colorectal cancer or adenomas, and randomized clinical trials of dietary fiber supplementation have failed to show reductions in the recurrence of colorectal adenomas.
- Natural Astaxanthin Detected in the Iris/Ciliary Body of the Eye
In a new study, natural astaxanthin extract (AstaREAL®) derived from Haematococcus microalgae was detected in the iris/ciliary body of New Zealand Albino (NZW) Rabbit Eyes 24 hours after ingestion.
- PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener
PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry.
- PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener
PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry.
- PureCircle Announces Exclusive Global Strategic Collaboration with Firmenich on All-Natural Zero-Calorie Sweetener
PureCircle has announced an exclusive global strategic collaboration with Firmenich to accelerate the commercialization of Reb A in the global food and beverage industry.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Kashi Company Introduces TLC™ Fruit & Grain Bars
Kashi Company has announced that it will expand its TLC(TM) family to include an original, new layered granola bar with the introduction of TLC Fruit & Grain Bars.
- Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health
Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study).
- Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health
Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study).
- Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health
Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study).
- Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health
Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study).
- Exotic Naturals Announces Start of Phase IIa Clinical Study for Male Sexual Health
Exotic Naturals is initiating a double blind placebo controlled dose determination clinical study for E-MA-H and E-MA-HP, two variants of a proprietary formula which is intended to perform as a sex stimulant (supported by an earlier pilot study).
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- New Manufacturers, Retailers and Education Show Strength of Natural, Organic and Healthy Products at Natural Products Expo West/SupplyExpo 2009
Natural Products Expo West/SupplyExpo will feature more than 1900 exhibiting companies and 300,000 square feet of natural, organic and specialty foods, supplements, and health and beauty, natural living, organic, and pet products. The trade show, produced by New Hope Natural Media, a division of Penton Media, will be held March 5-8, 2009 at the Anaheim Convention Center in California. Last year's event attracted a record-setting 52,000 attendees.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- Study Demonstrates that AHCC® Enhances Immune System by Increasing the Production of Key Dendritic Cells
A recently published study in Nutrition and Cancer (60(5), 643-651) by researchers at Kansai Medical University in Osaka, Japan has shown that AHCC (Active Hexose Correlated Compound) enhances immune function by increasing the number of dendritic cells (DCs). DCs are a key part of the immune system responsible for presenting foreign substances to other immune system cells.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
- KGK Synergize Inc. Announces GRAS Status For Sytrinol®
KGK Synergize Inc., has announced that it has received self affirmed GRAS (Generally Recognized as Safe) status for their flagship product, Sytrinol®. An independent panel of experts assembled by AIBMR Life Sciences, reviewed the product’s profile for safety, and approved its self-affirmed status.
|
Mount Laurel, NJ, December 1, 2005 - Fuji Health Science, Inc. (www.fujihealthscience.com), an American subsidiary of Fuji Chemical Industry Co., Ltd., Toyama, Japan announced today that the body of scientific research on astaxanthin for the specific benefit area of eye fatigue and accommodation has significantly increased. There are now seven (7) published human clinical studies relating astaxanthin to this benefit. All 7 studies were performed using AstaREAL® natural astaxanthin produced by Fuji Chemical. The studies were performed at different universities between 1999 and 2005. Four of the clinical studies were published in 2005. These added to the previous three eye fatigue clinical studies which were published 2002 to 2004. An eighth study on eye fatigue using AstaREAL is currently in progress and others are planned. Fuji Chemical also has two pending patents relating to this area of application.
According to Charles DePrince, President of Fuji Health Science, Inc., "Up to this point and throughout the industry astaxanthin research has looked like a dart board with small, single studies probing hopeful areas. However, this critical mass of research for eye fatigue is the first well researched area for astaxanthin and typical of Fuji's commitment to the development of scientific data for this exceptional carotenoid."
Other areas of study on astaxanthin that Fuji is actively pursuing include diabetes and diabetic nephropathy, cardiovascular, weight management and metabolic syndrome. Fuji is the leading producer of natural astaxanthin for human nutritional use in the world with state of the art cultivation and production facilities in both Maui, Hawaii and Gustavsberg, Sweden. Fuji’s astaxanthin products, AstaREAL® and AstaCarox®, are approved for use in nutritional supplementation in the U.S., Europe, and Japan, as well as other markets worldwide. Fuji Chemical also holds patents for astaxanthin in application areas such as physical and muscle endurance, gastric health, immune system, and fertility.
- END -
contact:
Yasuko Kuroda
Fuji Health Science, Inc.
contact@fujihealthscience.com
tel: 856 234 3636 fax: 856 778 2297
|